Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
Top PubMed Articles
99 results
  • Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction. [Case Reports]
    Pharmacotherapy 2009; 29(3):352-6DiGregorio RV, Pasikhova Y
  • A 75-year-old woman with diabetes mellitus, hypertension, and hyperlipidemia came to the emergency department with generalized and upper-extremity weakness; she had experienced a fall 2 months earlier. On admission, her drug therapy included lovastatin 40 mg/day, controlled-release diltiazem 240 mg/day, and glimepiride 1 mg/day. Nineteen days earlier, sitagliptin 100 mg/day had been started; it w…
  • Severe diarrhea in renal transplant patients: results of the DIDACT study. [Clinical Trial]
    Am J Transplant 2006; 6(6):1466-72Maes B, Hadaya K, … Squifflet JP
  • Diarrhea is common in transplant recipients. While the majority of cases are mild and transient, some are severe and prolonged, which can threaten graft survival through dehydration. While it is known that some immunosuppressive agents can elicit diarrhea, there does not appear to be any consensus on the role that other nonimmunosuppressive causes can play in transplant patients. The aim of the p…
  • Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. [Journal Article]
    PLoS One 2017; 12(8):e0179710Williams AD, Korolkova OY, … M'Koma AE
  • Inability to distinguish Crohn's colitis from ulcerative colitis leads to the diagnosis of indeterminate colitis. This greatly effects medical and surgical care of the patient because treatments for the two diseases vary. Approximately 30 percent of inflammatory bowel disease patients cannot be accurately diagnosed, increasing their risk of inappropriate treatment. We sought to determine whether …
  • Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature. [Case Reports]
    Rheumatol Int 2019; 39(2):337-344Krusche M, Ruffer N, Kötter I
  • Polyarteritis nodosa (PAN) is a rare systemic vasculitis affecting multiple organs. Current standard treatment includes the use of glucocorticoids and cyclophosphamide. Unfortunately, some patients do not respond to this treatment and other therapeutic options are needed. We present a case of a young male with refractory PAN and ongoing biopsy evidence of active vasculitis despite optimal standar…
New Search Next